Chong Kun Dang Pharmaceutical Corp. (KRX: 185750)

Chong Kun Dang Pharmaceutical Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Oct 11, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	1,442,262	1,665,714	1,001,821	1,312,267	2,572,971	1,049,862
Market Cap Growth	25.13%	66.27%	-23.66%	-49.00%	145.08%	-0.19%
Enterprise Value	1,321,639	1,643,508	1,090,151	1,317,516	2,555,291	1,080,450
Last Close Price	114200.00	130900.00	77546.69	98750.42	190322.77	77267.88
PE Ratio	6.81	7.84	12.28	30.17	27.31	18.87
PS Ratio	0.87	1.00	0.67	0.98	1.97	0.97
PB Ratio	1.65	2.04	1.61	2.32	4.66	2.21
P/FCF Ratio	6.57	6.01	43.87	-37.13	35.89	18.93
P/OCF Ratio	4.84	5.24	14.79	101.70	24.66	13.58
EV/Sales Ratio	0.79	0.98	0.73	0.98	1.96	1.00
EV/EBITDA Ratio	4.81	5.79	7.60	10.78	17.30	11.07
EV/EBIT Ratio	5.57	6.66	9.92	13.90	20.62	14.49
EV/FCF Ratio	6.02	5.93	47.74	-37.28	35.65	19.48
Debt / Equity Ratio	0.25	0.27	0.38	0.42	0.25	0.25
Debt / EBITDA Ratio	0.79	0.77	1.64	1.94	0.92	1.21
Debt / FCF Ratio	0.98	0.79	10.32	-6.71	1.90	2.13
Asset Turnover	1.26	1.32	1.37	1.35	1.49	1.43
Inventory Turnover	3.28	3.79	3.82	4.13	4.87	5.27
Quick Ratio	1.29	1.32	1.16	1.30	1.19	1.05
Current Ratio	1.99	1.85	1.91	2.08	1.87	1.70
Return on Equity (ROE)	27.69%	29.73%	13.47%	7.58%	17.61%	11.70%
Return on Assets (ROA)	11.15%	12.20%	6.33%	5.94%	8.86%	6.16%
Return on Capital (ROIC)	14.70%	16.29%	8.28%	7.95%	12.10%	8.26%
Earnings Yield	14.68%	12.76%	8.08%	3.26%	3.56%	5.13%
FCF Yield	15.23%	16.63%	2.28%	-2.69%	2.79%	5.28%
Dividend Yield	0.93%	0.80%	-	-	-	-
Payout Ratio	6.26%	5.46%	13.88%	25.30%	10.12%	16.40%
Buyback Yield / Dilution	0.51%	0.76%	1.77%	0.73%	0.06%	0.04%
Total Shareholder Return	1.44%	1.56%	1.77%	0.73%	0.06%	0.04%

Source: S&P Capital IQ. Standard template. Financial Sources.